Renal response after high-dose melphalan and stem cell transplantation is a favorable marker in patients with primary systemic amyloidosis

  • Nelson Leung
  • , Angela Dispenzieri
  • , Fernando C. Fervenza
  • , Martha Q. Lacy
  • , Rafael Villicana
  • , Joao L. Cavalcante
  • , Morie A. Gertz

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)270-277
Number of pages8
JournalAmerican Journal of Kidney Diseases
Volume46
Issue number2
DOIs
StatePublished - Aug 2005
Externally publishedYes

ASJC Scopus Subject Areas

  • Nephrology

Keywords

  • Melphalan
  • Primary systemic (AL) amyloidosis
  • Proteinuria
  • Renal
  • Response
  • Stem cell transplantation
  • Humans
  • Middle Aged
  • Male
  • Transplantation, Autologous
  • Kidney Function Tests
  • Melphalan/therapeutic use
  • Adult
  • Female
  • Kidney/physiopathology
  • Retrospective Studies
  • Treatment Outcome
  • Combined Modality Therapy
  • Amyloidosis/drug therapy
  • Survival Analysis
  • Proteinuria/etiology
  • Aged
  • Transplantation Conditioning
  • Peripheral Blood Stem Cell Transplantation
  • Cohort Studies

Cite this